Search Results - "Wetzko K"

Pulmonary adverse events in unrelated donors of peripheral blood stem cells.

Authors: Wetzko, K. Blechschmidt, M. Hölig, K. et al.

Source: Transfusion Medicine. Feb2013, Vol. 23 Issue 1, p69-71. 3p. 1 Black and White Photograph.

732MO The combination of ICT01, a γ9δ2 T cell-activating mAb, plus pembrolizumab induces a broad antitumor immune response and disease control in patients with CPI-failure melanoma, NSCLC and bladder cancer: EVICTION trial.

Authors: Champiat, S. Wermke, M. Vicier, C. et al.

Source: Annals of Oncology. 2022 Supplement 7, Vol. 33, pS877-S878. 2p.

Author Correction: Autologous T cell therapy for PRAME⁺ advanced solid tumors in HLA-A*02⁺ patients: a phase 1 trial.

Authors: Wermke M Araujo DM Chatterjee M et al.

Source: Nature medicine [Nat Med] 2025 Jul; Vol. 31 (7), pp. 2453.

Publication Type: Published Erratum

Journal Info: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE; PubMed not MEDLINE

Autologous T cell therapy for PRAME⁺ advanced solid tumors in HLA-A*02⁺ patients: a phase 1 trial.

Authors: Wermke M Araujo DM Chatterjee M et al.

Source: Nature medicine [Nat Med] 2025 Jul; Vol. 31 (7), pp. 2365-2374. Date of Electronic Publication: 2025 Apr 09.

Publication Type: Journal Article; Clinical Trial, Phase I; Multicenter Study

Journal Info: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE

First-in-human dose escalation trial to evaluate the clinical safety and efficacy of an anti-MAGEA1 autologous TCR-transgenic T cell therapy in relapsed and refractory solid tumors.

Authors: Wermke M Holderried TAW Luke JJ et al.

Source: Journal for immunotherapy of cancer [J Immunother Cancer] 2024 Jul 22; Vol. 12 (7). Date of Electronic Publication: 2024 Jul 22.

Publication Type: Journal Article; Clinical Trial, Phase I

Journal Info: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

Differences in Cellular Composition of Peripheral Blood Stem Cell Grafts from Healthy Stem Cell Donors Mobilized with Either Granulocyte Colony-Stimulating Factor (G-CSF) Alone or G-CSF and Plerixafor.

Authors: Teipel R Oelschlägel U Wetzko K et al.

Source: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation [Biol Blood Marrow Transplant] 2018 Nov; Vol. 24 (11), pp. 2171-2177. Date of Electronic Publication: 2018 Jun 21.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Carden Jennings Publishing Country of Publication: United States NLM ID: 9600628 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1523-6536 (Electronic) Linking ISSN: 10838791 NLM ISO Abbreviation: Biol Blood Marrow Transplant Subsets: MEDLINE

Transplants in myelodysplastic syndromes.

Authors: Wetzko K Platzbecker U

Source: Hematology/oncology clinics of North America [Hematol Oncol Clin North Am] 2014 Dec; Vol. 28 (6), pp. 1011-22. Date of Electronic Publication: 2014 Sep 29.

Publication Type: Journal Article; Review

Journal Info: Publisher: Elsevier Health Science Country of Publication: United States NLM ID: 8709473 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1558-1977 (Electronic) Linking ISSN: 08898588 NLM ISO Abbreviation: Hematol Oncol Clin North Am Subsets: MEDLINE